Moses-Payne Madeleine E, Rollwage Max, Fleming Stephen M, Roiser Jonathan P
Institute of Cognitive Neuroscience, University College London, London, United Kingdom.
Wellcome Trust Centre for Neuroimaging, University College London, London, United Kingdom.
Front Psychiatry. 2019 Sep 23;10:639. doi: 10.3389/fpsyt.2019.00639. eCollection 2019.
Metacognition, or the ability to reflect on one's own thoughts, may be important in the development of depressive symptoms. Recent work has reported that depressive symptoms were associated with lower metacognitive bias (overall confidence) during perceptual decision making and a trend toward a positive association with metacognitive sensitivity (the ability to discriminate correct and incorrect decisions). Here, we extended this work, investigating whether confidence judgments are more malleable in individuals experiencing depressive symptoms. We hypothesized that depressive symptoms would be associated with greater adjustment of confidence in light of new evidence presented after a perceptual decision had been made. Participants (N = 416) were recruited Amazon Mechanical Turk. Metacognitive confidence was assessed through two perceptual decision-making tasks. In both tasks, participants made a decision about which of two squares contained more dots. In the first task, participants rated their confidence immediately following the decision, whereas in the second task, participants observed new evidence (always in the same direction as initial evidence) before rating their confidence. Participants also completed questionnaires measuring depressive symptoms and self-esteem. Metacognitive bias was calculated as overall mean confidence, whereas metacognitive sensitivity was calculated using meta-d' (a response-bias free measure of how closely confidence tracks task performance) in the first task. Postdecision evidence integration (PDEI) was defined as the change in confidence following postdecision evidence on the second task. Participants with more depressive symptoms made greater confidence adjustments (i.e., greater PDEI) in light of new evidence (β = 0.119, p = 0.045), confirming our main hypothesis. We also observed that lower overall confidence was associated with greater depressive symptoms, although this narrowly missed statistical significance (β = -0.099, p = 0.056), and we did not find an association between metacognitive sensitivity (meta-d') and depressive symptoms. Notably, self-esteem was robustly associated with overall confidence (β = 0.203, p < 0.001), which remained significant when controlling for depressive symptoms. We found that individuals with depressive symptoms were more influenced by postdecisional evidence, adjusting their confidence more in light of new evidence. Individuals with low self-esteem were less confident about their initial decisions. This study should be replicated in a clinically depressed sample.
元认知,即反思自身思维的能力,可能在抑郁症状的发展中起重要作用。最近的研究报告称,在知觉决策过程中,抑郁症状与较低的元认知偏差(总体信心)相关,并且与元认知敏感性(区分正确和错误决策的能力)呈正相关趋势。在此,我们拓展了这项研究,调查在有抑郁症状的个体中,信心判断是否更具可塑性。我们假设,根据知觉决策做出后呈现的新证据,抑郁症状会与更大程度的信心调整相关。参与者(N = 416)通过亚马逊土耳其机器人平台招募。通过两项知觉决策任务评估元认知信心。在这两项任务中,参与者要决定两个方块中哪个包含更多的点。在第一项任务中,参与者在做出决策后立即对自己的信心进行评分,而在第二项任务中,参与者在对自己的信心进行评分之前会观察新证据(总是与初始证据方向相同)。参与者还完成了测量抑郁症状和自尊的问卷。元认知偏差计算为总体平均信心,而元认知敏感性在第一项任务中使用元d'(一种无反应偏差的测量方法,用于衡量信心与任务表现的紧密程度)进行计算。决策后证据整合(PDEI)定义为第二项任务中决策后证据出现后信心的变化。抑郁症状更严重的参与者根据新证据做出了更大的信心调整(即更大的PDEI;β = 0.119,p = 0.045),证实了我们的主要假设。我们还观察到总体信心较低与更严重的抑郁症状相关,尽管这一结果勉强未达到统计学显著性(β = -0.099,p = 0.056),并且我们未发现元认知敏感性(元d')与抑郁症状之间存在关联。值得注意的是,自尊与总体信心密切相关(β = 0.203,p < 0.001),在控制抑郁症状后这一关联仍然显著。我们发现,有抑郁症状的个体受决策后证据的影响更大,会根据新证据更大程度地调整自己的信心。自尊较低的个体对自己的初始决策信心较低。本研究应在临床抑郁症样本中进行重复验证。